His scientific interests lie mostly in Human leukocyte antigen, Immunology, MHC class I, Antigen and Molecular biology. Francisco Ruiz-Cabello interconnects Cancer research, Melanoma, Pathology, Loss of heterozygosity and Major histocompatibility complex in the investigation of issues within Human leukocyte antigen. Francisco Ruiz-Cabello has researched Melanoma in several fields, including Cytotoxic T cell and Immunotherapy.
His Immunology study integrates concerns from other disciplines, such as Downregulation and upregulation and Metastasis. His MHC class I research focuses on subjects like Lymphokine-activated killer cell, which are linked to CD30, HLA-E, Cell and NK-92. The Molecular biology study combines topics in areas such as Cell culture, Virus, DNA sequencing, Monoclonal antibody and Polymerase chain reaction.
Francisco Ruiz-Cabello focuses on Human leukocyte antigen, Immunology, Antigen, Molecular biology and Pathology. The concepts of his Human leukocyte antigen study are interwoven with issues in Cancer research, Melanoma, MHC class I, Major histocompatibility complex and Loss of heterozygosity. His Immunology research focuses on Cytotoxic T cell and how it relates to Tumor microenvironment.
His work in Antigen addresses issues such as Monoclonal antibody, which are connected to fields such as Virology. His Molecular biology research integrates issues from Cell culture, Cell and Mutation, Gene expression, Gene. His research on Pathology often connects related areas such as Cancer.
Human leukocyte antigen, Immunology, Cancer research, Immune system and Cytotoxic T cell are his primary areas of study. His work deals with themes such as T cell, Antigen presentation, Loss of heterozygosity and Immunotherapy, which intersect with Human leukocyte antigen. His Immunology study combines topics in areas such as Haplotype, Liver injury and Drug.
His studies deal with areas such as Bladder cancer, Cancer cell and Major histocompatibility complex as well as Cancer research. His study in Immune system is interdisciplinary in nature, drawing from both Infiltration and Pathology. His study explores the link between Cytotoxic T cell and topics such as Tumor microenvironment that cross with problems in MHC class I, Tumor-infiltrating lymphocytes, CTL* and Peripheral blood mononuclear cell.
Francisco Ruiz-Cabello mostly deals with Human leukocyte antigen, Immunology, Immune system, Infiltration and Pathology. His Human leukocyte antigen study incorporates themes from Phenotype, T cell, Immunotherapy, Cancer immunotherapy and Loss of heterozygosity. His Loss of heterozygosity research is multidisciplinary, incorporating perspectives in Primary tumor and Melanoma.
His research in Immunology intersects with topics in Bilirubin, Cytotoxic T cell and Allele, Haplotype. His Immune system research is multidisciplinary, incorporating elements of Cancer research and Stromal cell. When carried out as part of a general Pathology research project, his work on Lymphoma is frequently linked to work in Plasmacytoid dendritic cell, therefore connecting diverse disciplines of study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
IMPLICATIONS FOR IMMUNOSURVEILLANCE OF ALTERED HLA CLASS I PHENOTYPES IN HUMAN TUMOURS
Federico Garrido;Francisco Ruiz-Cabello;Teresa Cabrera;Juan J. Pérez-Villar.
Immunology Today (1997)
Natural history of HLA expression during tumour development
Federico Garrido;Teresa Cabrera;Angel Concha;Susan Glew.
Immunology Today (1993)
Susceptibility to Amoxicillin-Clavulanate-Induced Liver Injury is Influenced by Multiple HLA Class I and II Alleles
M. Isabel Lucena;Mariam Molokhia;Yufeng Shen;Thomas J. Urban.
The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape.
Ignacio Algarra;Angel García-Lora;Teresa Cabrera;Francisco Ruiz-Cabello.
Cancer Immunology, Immunotherapy (2004)
Rexpression of HLA class I antigens and restoration of antigen-specific CTL response in melanoma cells following 5-aza-2'-deoxycytidine treatment.
Alfonso Serrano;Silvia Tanzarella;Ilaria Lionello;Rosa Mendez.
International Journal of Cancer (2001)
High frequency of altered HLA class I phenotypes in invasive colorectal carcinomas
T. Cabrera;A. Collado;M.A. Fernandez;A. Ferron.
Human Immunology (1996)
Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways: β2-microglobulin inactivation in MSI-positive tumors and LMP7/TAP2 downregulation in MSI-negative tumors
C M Cabrera;P Jiménez;T Cabrera;C Esparza.
Tissue Antigens (2003)
Analysis of HLA-E expression in human tumors.
Rosario Marín;Francisco Ruiz-Cabello;Susana Pedrinaci;Rosa Méndez.
HLA class I antigens in human tumors.
Federico Garrido;Teresa Cabrera;Miguel Angel Lopez-Nevot;Francisco Ruiz-Cabello.
Advances in Cancer Research (1995)
Role of Altered Expression of HLA Class I Molecules in Cancer Progression
Natalia Aptsiauri;Teresa Cabrera;Rosa Mendez;Angel Garcia-Lor.
Advances in Experimental Medicine and Biology (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: